ZYVOX I.V. Injection is available in single-dose, ready-to-use flexible plastic infusion bags in a foil laminate overwrap. The infusion bags and ports are not made with natural rubber latex. The infusion bags are available in the following package sizes:
200 mg/100 mL (2 mg/mL) linezolid × 10 | NDC 0009-5137-04 |
600 mg/300 mL (2 mg/mL) linezolid × 10 | NDC 0009-5140-04 |
ZYVOX Tablets are available as follows:
600 mg (white, capsule-shaped, film-coated tablets debossed with "ZYV" on one side and "600" on the other)
20 tablets in HDPE bottle | NDC 0009-5138-02 |
Unit dose packages of 30 tablets | NDC 0009-5138-03 |
ZYVOX for Oral Suspension is available as a dry, white to off-white, orange-flavored granule/powder. When constituted as directed, each bottle will contain 150 mL of a suspension providing the equivalent of 100 mg of linezolid per each 5 mL. ZYVOX for Oral Suspension is supplied as follows:
100 mg/5 mL in 240 mL glass bottles | NDC 0009-5136-01 |
100 mg/5 mL in 240 mL glass bottles | NDC 0009-5136-04 |
ZYVOX I.V. Injection is available in single-dose, ready-to-use flexible plastic infusion bags in a foil laminate overwrap. The infusion bags and ports are not made with natural rubber latex. The infusion bags are available in the following package sizes:
200 mg/100 mL (2 mg/mL) linezolid × 10 | NDC 0009-5137-04 |
600 mg/300 mL (2 mg/mL) linezolid × 10 | NDC 0009-5140-04 |
ZYVOX Tablets are available as follows:
600 mg (white, capsule-shaped, film-coated tablets debossed with "ZYV" on one side and "600" on the other)
20 tablets in HDPE bottle | NDC 0009-5138-02 |
Unit dose packages of 30 tablets | NDC 0009-5138-03 |
ZYVOX for Oral Suspension is available as a dry, white to off-white, orange-flavored granule/powder. When constituted as directed, each bottle will contain 150 mL of a suspension providing the equivalent of 100 mg of linezolid per each 5 mL. ZYVOX for Oral Suspension is supplied as follows:
100 mg/5 mL in 240 mL glass bottles | NDC 0009-5136-01 |
100 mg/5 mL in 240 mL glass bottles | NDC 0009-5136-04 |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.